Deraphar
ActiveSummary
Deraphar has been active since 1989 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €270,143 and a net result of -€88,165. Equity is growing by about 4.1% per year across the filed financial years. Its solvency ranks better than 48% of 12,661 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.8% (low).
Register details
Identification
Legal formPrivate limited company
Founded04-12-1989
Financial year end31-12
Activities, NACEBEL 2025
47730Retail sale of pharmaceutical products
E-invoicing
Reachable via Peppol
Peppol ID
0208:0439109003
Also
9925:BE0439109003
Registered
28-08-2023
If you follow this company, Checked tells you the day it leaves the Peppol register.
Register as of 24 October 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.
Recognitions · licences · registrations
Food safety, FASFC
1 siteZelzateunit no. 2.046.581.026
Environmental permits: No permit applications found in Flanders. Brussels and Wallonia do not publish the applicant.
Sites & property
Location & real-estate footprint
Registered office, Zelzate · 1 establishment unit since 1989
Ground area
123 m²
Building footprint
123 m²
Building volume
1,458 m³
Parcel 43018A0509/00D002, Flanders · tallest building 19.8 m. Linked by address, not a title deed.
1 establishment unit
Deraphar
since 1989unit no. 2.046.581.026
1 parcel
Flanders
1
(100%)
| Cadastral parcel | Region | Area | Buildings | Height / floors |
|---|---|---|---|---|
| 43018A0509/00D002 | Flanders | 123 m² | 1 · 123 m² | 19.8 m · 5 |
How the parcels are linked
Good to know
The parcel matches the address exactly.